Biden Just Went Against His Voters, Sided with China on Solar
Voters support locally made solar. So why is the Biden administration giving China companies under investigation for trade violations in SE Asia duty-free access to the U.S.?
Voters support locally made solar. So why is the Biden administration giving China companies under investigation for trade violations in SE Asia duty-free access to the U.S.?
The Food and Drug Administration recently updated its drug shortage list. More than half of the updates include drugs on the essential medicines list.
Senator Burr warned the FDA that until the Senate is okay with their response to the infant formula crisis, and present a plan to prevent it in the future, the Generic Drug User Fee Authorization bill might be put on hold.
Press reports say that Treasury Secretary Janet Yellen is arguing for repealing a broad set of U.S. tariffs, allegedly as a way to fight inflation.
Solar and steel tariffs helped the industry expand. Here is where the naysayers were wrong about rising prices and market destruction due to anti-dumping charges and other trade remedies.
For years, mainstream politicians and economists have pooh-poohed America’s huge and growing trade deficits and tried to argue they don’t matter. In the first quarter
The U.S. China Economic and Security Review Commission discussed the tight-linked China-India pharmaceutical supply chain, and tossed aside the notion that sweeping trade deals with India and the region are good ideas.
By Amanda Mayoral Summary Global supply-chain crises, over-dependence on foreign production and government stimulus best explain the current inflation problem. Policy makers should
The Senate Intelligence Committee discusses China’s strategy for economic and technological dominance. Senator Marco Rubio wonders if China will hold supply chains hostage.
The Health subcommittee of the House Energy and Commerce Committee have moved the FDA user-fee reauthorization bill to final committee. Chairwoman Eshoo says it is on track for September approval.